Understanding of molecular pathogenesis of Alzheimer's disease: Implications for drug development

Folia Pharmacologica Japonica

Volumn 115, Issue 2, 2000, Pages 79-88

  Takeda, Masatoshi ^a   Shinosaki, Kazuhiro ^a   Nishikawa, Takashi ^a   Tanaka, Toshihisa ^a   Kudo, Takashi ^a   Nakamura, Yu ^a   Kashiwagi, Yujiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Notch; Presenilin; Prolyl isomerase

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYCLOPHILIN; CYCLOSPORIN; NOOTROPIC AGENT; NOTCH RECEPTOR; PRESENILIN 1; PROLYL ISOMERASE; PROLYL ISOMERASE PIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN; TACROLIMUS; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL TISSUE; MOLECULAR BIOLOGY; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033962301     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.115.79     Document Type: Review

References (41)

1. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC and Selkoe DJ: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3, 16-32 (1996)
2. Mann DM, Iwatsubo T, Fukumoto H, Ihara Y, Odaka A and Suzuki N: Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques. Acta Neuropathol 90, 472-477 (1995)
3. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706 (1991)
4. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, Luyendijk W and Frangione B: Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126 (1990)
5. Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin JJ, et al: Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1, 218-221 (1992)
6. Biere AL, Ostaszewski B, Zhao H, Gillespie S, Younkin SG and Selkoe DJ: Co-expression of beta-amyloid precursor protein (betaAPP) and apolipo-protein E in cell culture: analysis of betaAPP processing. Neurobiol Dis 2, 177-187 (1995)
7. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D and Roses AD: Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90, 9649-9653 (1993)
8. Rebeck GW, Reiter JS, Strickland DK and Hyman BT: Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580 (1993)
9. Ma J, Yee A, Brewer HB Jr, Das S and Potter H: Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372, 92-94 (1994)
10. Evans KC, Berger EP, Cho CG, Weisgraber KH and Lansbury PT Jr: Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 92, 763-767 (1995)
11. Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, et al: Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 17, 263-264 (1997)
12. Logeat F, Bessia C, Brou C, LeBail O, Jarriault S, Seidah NG and Israel A: The Notchl receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci USA 95, 8108-8112 (1998)
13. Blaumueller CM, Qi H, Zagouras P and ArtavanisTsakonas S: Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell 90, 281-291 (1997)
14. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 7154-760 (1995)
15. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, et al: Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778 (1995)
16. Levitan D, Doyle TG, Brousseau D, Lee MK, Thinakaran G , Slunt HH , Sisodia SS and Greenwald I: Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci USA 93, 14940-14944 (1996)
17. Baumeister R. Leimer U, Zweckbronner I, Jakubek C, Grunberg J and Haass C: Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Function 1, 149-159 (1997)
18. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, Chen HY, Price DL, Van der Ploeg LH and Sisodia SS: Presenilin 1 is required for Notchl and Dili expression in the paraxial mesoderm. Nature 387, 288-292 (1997)
19. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ and Tonegawa S: Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639 (1997)
20. Qian S, Jiang P, Guan XM, Singh G, Trumbauer ME, Yu H, Chen HY, Van de Ploeg LH and Zheng H: Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abetal-42/43 expression. Neuron 20, 611-617 (1998)
21. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, Ratovitsky T, Davenport F, Nordstedt C, Seeger M, et al: Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190 (1996)
22. Podlisny MB, Citron M, Amarante P, Sherrington R, Xia W, Zhang J, Diehl T, Levesque G, Fraser P, Haass C, et al: Presenilin proteins undergo heterogenous endoproteolysis between Thr291 and Ala 299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis 3, 325-337 (1997)
23. Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH, Price DL, Borchelt DR and Sisodia SS: Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem 272, 28415-28422 (1997)
24. Steiner H, Capell A, Pesold B, Citron M, Kloetzel PM, Selkoe DJ, Romig H, Mendla K and Haass C: Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J Biol Chem 273, 32322-32331 (1998)
25. Capell A, Grunberg J, Pesold B, Diehlmann A, Citron M, Nixon R, Beyreuther K, Selkoe DJ and Haass C: The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J Biol Chem 273, 3205-3211 (1998)
26. Zhang J, Kang DE, Xia W, Okochi M, Mori H, Selkoe DJ and Koo EH: Subcellular distribution and turnover of presenilins in transfected cells. J Biol Chem 273, 12436-12442 (1998)
27. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, Yamaguchi H, Ruiz A, Martinez A, Madrigal L, et al: The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med 2, 1146-1150 (1996)
28. Mann DM, Iwatsubo T, Cairns NJ, Lantos PL, Nochlin D, Sumi SM, Bird TD, Poorkaj P, Hardy J, Hutton M, et al: Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42 (43). Ann Neurol 40, 149-156 (1996)
29. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, et al: Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2, 864-870 (1996)
30. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, et al: Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4, 97-100 (1998)
31. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT and Selkoe DJ: Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513-517 (1999)
32. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K , Mumm JS , Schroeter EH , Schrijvers V, Wolfe MS, Ray WJ, et al: A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518-522 1999)
33. Struhl G and Greenwald I: Presenilin is required for activity and nuclear access of Notch in drosophila. Nature 398, 522-525 (1999)
34. Ye Y, Lukinova N and Fortini ME: Neurogenic phenotypes and altered Notch processing in drosophila presenilin mutants. Nature 398, 525-529 (1999)
35. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F and Cole G: Correlative memory deficits, Abetaelevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996)
36. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, et al: Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527 (1995)
37. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, et al: Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177 (1999)
38. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, et al: Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705 (1998)
39. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A and Ghetti B: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95, 7737-7741 (1998)
40. Lu PJ, Wulf G, Zhou XZ, Davies P and Lu KP: The prolyl isomerase Pin 1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784-788 (1999)
41. Lu KP, Hanes SD and Hunter T: A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380 (6574), 544-547 (1996)